A Randomized, Single-Blinded, Vehicle-Controlled Study of a Topical Active Blend in the Treatment of Androgenetic Alopecia

    May 2020 in “ Dermatologic Therapy
    Alexander C. Katoulis, Aikaterini I. Liakou, Dimitra Koumaki, Efstratios Vakirlis, Andreas G Tsantes, Despina Mortaki, E. Bozi, D. Ioannides
    New to Redensyl? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this study, a topical lotion containing Redensyl and Sepicontrol A5 demonstrated effectiveness for treating androgenetic alopecia over 24 weeks, with 73.1% of users seeing moderate improvement and notable increases in hair cycle ratios, alongside enhanced quality of life and satisfaction. Our plain-language summary of this paper — not a Tressless recommendation.
    The study evaluated the effectiveness of a topical lotion called Redenyl in treating androgenetic alopecia (AGA). The lotion contains two patented formulas: Redensyl and Sepicontrol A5. The study was conducted as a randomized, single-blinded, vehicle-controlled study with 44 patients diagnosed with AGA. The results showed that Redenyl was effective in promoting hair growth and improving patients' quality of life, with no significant side effects. The study suggests that Redenyl may be a promising new treatment option for AGA.
    Discuss this study in the Community →

    Research cited in this study

    22 / 22 results